Concepedia

Marion Bettey

MB

Statistics

Publications

6

Citations

375

H-Index

6

Active since

2016

Affiliations

University of Southampton(Current)

University Hospital Southampton NHS Foundation Trust

Barts Health NHS Trust

Centre for Inflammation Research

St Mark's Hospital

Marion Bettey is an author at University of Southampton specializing in inflammatory bowel disease, pharmacotherapy, and inflammatory bowel disease therapy.

Publications per year

2016–2022

6

Publications

6

Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme

Violeta Razanskaite, Marion Bettey, Louise Downey et al. · Journal of Crohn s and Colitis · 2017 · 157 citations · Full text

, , +15

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

, , +17

Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]

Esther Ventress, David Young, Sohail Rahmany et al. · Journal of Crohn s and Colitis · 2021 · 54 citations · Full text

, , +14

Early real-world effectiveness of ustekinumab for Crohn’s disease

Richard Harris, Martin B. McDonnell, David Young et al. · Frontline Gastroenterology · 2019 · 35 citations · Full text

, , +17

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

, , +17

1–5 of 6